{"id":"NCT02445807","sponsor":"Promius Pharma, LLC","briefTitle":"A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis","officialTitle":"A Randomized, Double-Blind, Vehicle-Controlled, Multicenter, Parallel Group Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis for 14 Days","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-12","primaryCompletion":"2016-07","completion":"2016-07","firstPosted":"2015-05-15","resultsPosted":"2018-04-13","lastUpdate":"2018-05-15"},"enrollment":265,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Stable Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"DFD06-Cream","otherNames":["Clobetasol propionate Cream, 0.025%"]},{"type":"DRUG","name":"Vehicle Cream","otherNames":[]}],"arms":[{"label":"DFD-06 cream","type":"EXPERIMENTAL"},{"label":"Vehicle Cream","type":"PLACEBO_COMPARATOR"}],"summary":"This study will compare the efficacy and safety of DFD-06 Cream to Vehicle Cream for topical treatment of moderate to severe plaque psoriasis after 3, 7, and 14 days of treatment.","primaryOutcome":{"measure":"Efficacy (Percentage of Subjects With Treatment Success)","timeFrame":"Day 15 Visit","effectByArm":[{"arm":"DFD-06 Cream","deltaMin":30.1,"sd":null},{"arm":"Vehicle Cream","deltaMin":9.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":30,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":176},"commonTop":["Application Site Pain","Application Site Pruritus","Application Site Fissure","application site discolouration","Vomiting"]}}